Who Will Pay for the COVID-19 Vaccines for Africa? #MMPMID33427194
Lucero-Prisno DE; Ogunkola IO; Imo UF; Adebisi YA
Am J Trop Med Hyg 2021[Jan]; 104 (3): 794-796 PMID33427194show ga
Africa's health systems are strained by the COVID-19 pandemic. There are global efforts toward the development and trial of COVID-19 vaccines. However, considering the challenges and economic conditions of African nations, there could be limited access and availability of the vaccines on the continent. This will be the result of high cost and technical requirements to acquire the vaccines. There are indications that possible donor funding for COVID-19 vaccines from rich countries maybe put off considering the various challenges they face currently and the moves they are making in response to the disease. The issue of justice in health for protecting the vulnerable populations and regions also supports the need for COVID-19 vaccine availability on the African continent. Means to achieve uniform control of the disease burden across the globe should be adopted. Governments of African nations should also scale up their efforts toward COVID-19 vaccine acquisition and utilization through viable efforts. It is therefore important to assist the African continent in acquiring the COVID-19 vaccines by leveling all power dynamics that will affect access and distribution.
free
free
free
Am+J+Trop+Med+Hyg 2021 ; 104 (3): 794-796
